Emerging Drug Discovery Strategies for Targeted Protein Degradation
In the last decade, targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific disease-related proteins using cellular self-destruction mechanisms. In our latest White Paper, “Emerging Drug Discovery Strategies for Targeted Protein Degradation” we explore how DNA-encoded library (DEL) technology can be used for direct discovery of proteolysis-targeting chimeras and to identify ligands intended for development of bifunctional molecules. We also discuss linker optimization, biological characterization, DMPK optimization, and formulation strategies.
Check out our comprehensive platform of TPD services by clicking HERE

White Paper_Targeted Protein Degradation
Related Content
In our latest publication, WuXi AppTec scientists introduce two new methods that utilize readily accessible aldehydes to create substituted isoxazolines...
VIEW RESOURCEIndoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that metabolizes tryptophan, and its activity can lead to immunosuppression, thereby allowing tumors...
VIEW RESOURCE
